Molecular Insight Reviews

Recommend to a friend
Approve of CEO
(no image)
Harry Stylli
1 Rating
  • Good Science with bad accounting

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee in Cambridge, MA
    Former Employee - Anonymous Employee in Cambridge, MA

    I worked at Molecular Insight full-time (More than a year)

    Doesn't Recommend
    Negative Outlook
    Approves of CEO
    Doesn't Recommend
    Negative Outlook
    Approves of CEO


    Great work/life balance without scientific compromise


    Closed after acquisition to out-of-state firm

Molecular Insight Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Sleepy Hollow, 061
Size 50 to 149 Employees
Founded Unknown
Type Company - Private
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year
Competitors Immunomedics, DRAXIS

Molecular Insight Pharmaceuticals (MIP) is working to make cancer invisible. The development-stage company is focused on making molecular imaging and radiotherapeutic products that help diagnose and treat various diseases by combining radiation therapy with biochemical and molecular science. MIP is focused on oncology and has diagnostic and radiotherapeutic candidates under development in areas including prostate cancer, neuroendocrine cancers, and metastatic melanoma. It is also developing a cardiovascular diagnostic imaging agent that highlights distressed areas of the ... More

Work at Molecular Insight? Share Your Experiences

Molecular Insight

Click to Rate